Bone Biologics logo

Bone Biologics Share Price (NASDAQ: BBLG)

$2.16

Last updated on

Check the interactive Bone Biologics Stock chart to analyse performance

Bone Biologics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.15
    Today's High:$2.16

    Day's Volatility :0.46%

  • 52 Weeks Low:$2.08
    52 Weeks High:$16.50

    52 Weeks Volatility :87.39%

Bone Biologics Stock Returns

PeriodBone Biologics CorpIndex (Russel 2000)
3 Months
-56.08%
0.0%
6 Months
-56.18%
0.0%
1 Year
-68.97%
0.0%
3 Years
-99.89%
-4.7%

Bone Biologics Corp Key Stats

Check Bone Biologics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.16
Open
$2.15
Today's High
$2.16
Today's Low
$2.15
Market Capitalization
$3.9M
Today's Volume
$11.4K
52 Week High
$16.5
52 Week Low
$2.08
Revenue TTM
$0.0
EBITDA
$-825.0K
Earnings Per Share (EPS)
$-21.39
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-88.8%

Stock Returns calculator for Bone Biologics Stock including INR - Dollar returns

The Bone Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bone Biologics investment value today

Current value as on today

₹36,319

Returns

₹63,681

(-63.68%)

Returns from Bone Biologics Stock

₹68,966 (-68.97%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Bone Biologics Stock

-62%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Bone Biologics Stock from India on INDmoney has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Bone Biologics Corp

  • Name

    Holdings %

  • Geode Capital Management, LLC

    0.24%

  • Tower Research Capital LLC

    0.01%

Analyst Recommendation on Bone Biologics Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Bone Biologics(by analysts ranked 0 to 5 stars)

Bone Biologics Share Price Target

What analysts predicted

Upside of 941.67%

Target:

$22.50

Current:

$2.16

Bone Biologics share price target is $22.50, a slight Upside of 941.67% compared to current price of $2.16 as per analysts' prediction.

Bone Biologics Stock Insights

  • Price Movement

    In the last 1 month, BBLG stock has moved down by -22.0%
  • BBLG vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 103.3%
  • BBLG vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 263.4%

Bone Biologics Technicals Summary

Sell

Neutral

Buy

Bone Biologics is currently in a neutral trading position according to technical analysis indicators.

Bone Biologics Corp Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Bone Biologics Corp logo
-20.88%
-56.18%
-68.97%
-99.89%
-99.97%
Medtronic Plc logo
3.87%
-1.59%
4.32%
4.82%
-13.69%
Edwards Lifesciences Corp. logo
2.55%
13.95%
18.33%
-9.73%
-5.31%
Boston Scientific Corp. logo
0.09%
0.6%
30.02%
157.38%
154.4%
Stryker Corporation logo
3.63%
-0.85%
8.87%
89.43%
97.71%
Abbott Laboratories logo
5.15%
-5.37%
15.72%
26.56%
24.53%

About Bone Biologics Corp

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Organization
Bone Biologics
Employees
2
CEO
Mr. Jeffrey Frelick
Industry
Biotechnology

Key Management of Bone Biologics Corp

NameTitle
Mr. Jeffrey Frelick
CEO & President

Important FAQs about investing in BBLG Stock from India :

What is Bone Biologics share price today?

Bone Biologics share price today is $2.16 as on at the close of the market. Bone Biologics share today touched a day high of $2.16 and a low of $2.15.

What is the 52 week high and 52 week low for Bone Biologics share?

Bone Biologics share touched a 52 week high of $16.50 and a 52 week low of $2.08. Bone Biologics stock price today i.e. is closed at $2.16, lower by 86.91% versus the 52 week high.

How to invest in Bone Biologics Stock (BBLG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bone Biologics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bone Biologics Shares that will get you 0.6944 shares as per Bone Biologics share price of $2.16 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bone Biologics Stock (BBLG) from India?

Indian investors can start investing in Bone Biologics (BBLG) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Bone Biologics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Bone Biologics share’s latest price of $2.16 as on August 30, 2025 at 1:29 am IST, you will get 4.6296 shares of Bone Biologics. Learn more about fractional shares .

What are the returns that Bone Biologics has given to Indian investors in the last 5 years?

Bone Biologics stock has given -99.97% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?